Adenosine A2A Receptor Mediated Protective Effect of 2-(6-cyano-1-hexyn-1-yl)adenosine on Retinal Ischaemia/reperfusion Damage in Rats

Overview

Journal Br J Ophthalmol

Specialty Ophthalmology

Date 2006 Apr 15

PMID 16613921

Citations 5

Authors

T Konno

A Sato

T Uchibori

A Nagai

K Kogi

N Nakahata

Affiliations

Soon will be listed here.

Abstract

Aims: To determine the effect of 2-(6-cyano-1-hexyn-1-yl)adenosine (2-CN-Ado), an adenosine A2A receptor agonist, on retinal ischaemia/reperfusion damage in rats.

Methods: Retinal ischaemia/reperfusion damage was induced by elevating the intraocular pressure of one eye to 130 mm Hg for 60 minutes and returning it to normal. 7 days later, retinal ischaemia/reperfusion damage was histologically quantified by measuring the thickness of retinal layers. Intraocular pressure was measured by pressure transducer.

Results: Retinal ischaemia/reperfusion caused cell loss in the ganglion cell layer and thinning of the inner plexiform and nuclear layer. Both ocular topical and intravenous administration of 2-CN-Ado caused a reduction of retinal ischaemia/reperfusion damage. A selective A2A receptor antagonist, 1,3,7-trimethyl-8-(3-chlorostyryl) xanthine (CSC), but not a selective A1 receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), or a selective A2B receptor antagonist, alloxazine, reduced the protective effect of 2-CN-Ado. While ocular topical administration of 2-CN-Ado caused a sustained reduction of intraocular pressure, intravenous administration of 2-CN-Ado showed a transient ocular hypotensive effect.

Conclusions: These results suggest that 2-CN-Ado attenuates retinal ischaemia/reperfusion damage, and at least some of this protective effect of 2-CN-Ado might be mediated via activation of the adenosine A2A receptor.

Citing Articles

Caffeine and Its Neuroprotective Role in Ischemic Events: A Mechanism Dependent on Adenosine Receptors.

Pereira-Figueiredo D, Nascimento A, Cunha-Rodrigues M, Brito R, Calaza K Cell Mol Neurobiol. 2021; 42(6):1693-1725.

PMID: 33730305 PMC: 11421760. DOI: 10.1007/s10571-021-01077-4.

The effects of bevacizumab treatment in a rat model of retinal ischemia and perfusion injury.

Kohen M, Tatlipinar S, Cumbul A, Uslu U Mol Vis. 2018; 24:239-250.

PMID: 29681725 PMC: 5893009.

Role of microglia adenosine A(2A) receptors in retinal and brain neurodegenerative diseases.

Santiago A, Baptista F, Santos P, Cristovao G, Ambrosio A, Cunha R Mediators Inflamm. 2014; 2014:465694.

PMID: 25132733 PMC: 4124703. DOI: 10.1155/2014/465694.

Ischemia-reperfusion injury induces occludin phosphorylation/ubiquitination and retinal vascular permeability in a VEGFR-2-dependent manner.

Muthusamy A, Lin C, Shanmugam S, Lindner H, Abcouwer S, Antonetti D J Cereb Blood Flow Metab. 2014; 34(3):522-31.

PMID: 24398936 PMC: 3948134. DOI: 10.1038/jcbfm.2013.230.

Minocycline prevents retinal inflammation and vascular permeability following ischemia-reperfusion injury.

Abcouwer S, Lin C, Shanmugam S, Muthusamy A, Barber A, Antonetti D J Neuroinflammation. 2013; 10:149.

PMID: 24325836 PMC: 3866619. DOI: 10.1186/1742-2094-10-149.

References

Larsen A, Osborne N . Involvement of adenosine in retinal ischemia. Studies on the rat. Invest Ophthalmol Vis Sci. 1996; 37(13):2603-11. View

Sullivan G . Adenosine A2A receptor agonists as anti-inflammatory agents. Curr Opin Investig Drugs. 2004; 4(11):1313-9. View

Braunagel S, Xiao J, Chiou G . The potential role of adenosine in regulating blood flow in the eye. J Ocul Pharmacol. 1988; 4(1):61-73. DOI: 10.1089/jop.1988.4.61. View

Matsuda A, Shinozaki M, Yamaguchi T, Homma H, Nomoto R, Miyasaka T . Nucleosides and nucleotides. 103. 2-Alkynyladenosines: a novel class of selective adenosine A2 receptor agonists with potent antihypertensive effects. J Med Chem. 1992; 35(2):241-52. DOI: 10.1021/jm00080a007. View

Seki M, Tanaka T, Matsuda H, Togano T, Hashimoto K, Ueda J . Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model. Br J Ophthalmol. 2005; 89(4):504-7. PMC: 1772601. DOI: 10.1136/bjo.2004.052860. View

Kaushik S, Pandav S, Ram J . Neuroprotection in glaucoma. J Postgrad Med. 2003; 49(1):90-5. DOI: 10.4103/0022-3859.917. View

Osborne N, Melena J, Chidlow G, Wood J . A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma. Br J Ophthalmol. 2001; 85(10):1252-9. PMC: 1723727. DOI: 10.1136/bjo.85.10.1252. View

Weber M, BONAVENTURE N, Sahel J . Protective role of excitatory amino acid antagonists in experimental retinal ischemia. Graefes Arch Clin Exp Ophthalmol. 1995; 233(6):360-5. DOI: 10.1007/BF00200485. View

Li B, Rosenbaum P, Jennings N, Maxwell K, Roth S . Differing roles of adenosine receptor subtypes in retinal ischemia-reperfusion injury in the rat. Exp Eye Res. 1999; 68(1):9-17. DOI: 10.1006/exer.1998.0573. View

10.

Pop E . Trends in neuroprotection. Arch Soc Esp Oftalmol. 2002; 77(6):295-7. View

11.

Harada N, Okajima K, Murakami K, Usune S, Sato C, Ohshima K . Adenosine and selective A(2A) receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation. J Pharmacol Exp Ther. 2000; 294(3):1034-42. View

12.

Stefansson E, Wilson C, Schoen T, Kuwabara T . Experimental ischemia induces cell mitosis in the adult rat retina. Invest Ophthalmol Vis Sci. 1988; 29(7):1050-5. View

13.

Paul S, Feoktistov I, Hollister A, Robertson D, Biaggioni I . Adenosine inhibits the rise in intracellular calcium and platelet aggregation produced by thrombin: evidence that both effects are coupled to adenylate cyclase. Mol Pharmacol. 1990; 37(6):870-5. View

14.

Hein T, Yuan Z, Rosa Jr R, Kuo L . Requisite roles of A2A receptors, nitric oxide, and KATP channels in retinal arteriolar dilation in response to adenosine. Invest Ophthalmol Vis Sci. 2005; 46(6):2113-9. DOI: 10.1167/iovs.04-1438. View

15.

Ffytche T . A rationalization of treatment of central retinal artery occlusion. Trans Ophthalmol Soc U K (1962). 1974; 94(2):468-79. View

16.

Ferreira J, Paes-de-Carvalho R . Long-term activation of adenosine A(2a) receptors blocks glutamate excitotoxicity in cultures of avian retinal neurons. Brain Res. 2001; 900(2):169-76. DOI: 10.1016/s0006-8993(01)02279-x. View

17.

Konno T, Murakami A, Uchibori T, Nagai A, Kogi K, Nakahata N . Involvement of adenosine A2a receptor in intraocular pressure decrease induced by 2-(1-octyn-1-yl)adenosine or 2-(6-cyano-1-hexyn-1-yl)adenosine. J Pharmacol Sci. 2005; 97(4):501-9. DOI: 10.1254/jphs.fp0040730. View

18.

Ghiardi G, Gidday J, Roth S . The purine nucleoside adenosine in retinal ischemia-reperfusion injury. Vision Res. 1999; 39(15):2519-35. DOI: 10.1016/s0042-6989(99)00038-3. View

19.

Matsugi T, Chen Q, Anderson D . Adenosine-induced relaxation of cultured bovine retinal pericytes. Invest Ophthalmol Vis Sci. 1998; 38(13):2695-701. View

20.

Osborne N, Casson R, Wood J, Chidlow G, Graham M, Melena J . Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res. 2004; 23(1):91-147. DOI: 10.1016/j.preteyeres.2003.12.001. View